Concomitant mutations in IDH1/2 were associated with a decreased risk of death, although this did not reach statistical significance (HR = 0.29; 95% CI = 0.08–1.08; P = 0.065).
← all excerpts
Prognostic impact of clinico-genetic characteristics and donor types in <i>NPM1</i>-mutated AML undergoing allogeneic hematopoietic stem cell transplantation.
1
0.0650
0.0650